PAROLE IN INGLESE ASSOCIATE CON «KALLIKREIN»
kallikrein
inhibitor
unit
pronunciation
saliva
kallikreins
subgroup
serine
proteases
enzymes
capable
cleaving
peptide
bonds
proteins
humans
plasma
known
homologue
while
tissue
related
peptidases
encode
plasmin
plasminogen
kinin
systems
activated
coagulation
factor
xiia
klkb
cleaves
high
molecular
weight
kininogen
release
bradykinin
potent
vasodilator
kallikrein
merriam
webster
hypotensive
protease
that
liberates
kinins
from
used
therapeutically
vasodilation
origin
german
greek
enzyme
research
laboratories
learn
more
about
view
certificate
analysis
call
place
order
medical
kal″ĭ
several
proteinases
cleave
kininogens
form
hydrolase
international
symposium
great
pleasure
welcome
basic
clinician
scientists
annual
activation
system
endothelial
cells
than
decades
been
only
occurs
when
exposed
artificial
negatively
charged
define
kāl
krē
present
lymph
urine
pancreatic
juices
other
body
fluids
catalyzes
precursor
homo
sapiens
fletcher
10 LIBRI IN INGLESE ASSOCIATI CON «KALLIKREIN»
Scopri l'uso di
kallikrein nella seguente selezione bibliografica. Libri associati con
kallikrein e piccoli estratti per contestualizzare il loro uso nella letteratura.
1
Regulation of
Kallikrein 6 Gene Expression and Protein ...
Colon cancer occurs in over 150,000 men and women in the United States each year and is fatal about one third of the time.
Rebecca Sue Henkhaus, 2008
2
Advanced Therapy in Cardiac Surgery
Surgical Procedure CPB Humoral Inflammatory Systems • Coagulation •
Kallikrein • l-jhrinolysis • Complement Cellular Activation • Neutrophils •
Monocytes • ilndothelial cells • Platelets Inflammatory Mediators • Cytokines •
Chemokines ...
3
Activation Profiles and Regulatory Cascades of the Human ...
Much recent work has been devoted to elucidating the potential for activation cascades between members of the KLK family, with physiologically relevant KLK regulatory cascades now described in skin desquamation and semen liquefaction.
4
Molecular Biology and Biotechnology: A Comprehensive Desk ...
Since the new T-kininogen gene product was no longer susceptible to cleavage
by kallikrein to yield kinins and also not able to participate as a cofactor in the
blood coagulation cascade, it has been proposed that T-kininogen expression ...
5
Principles and Practice of Endocrinology and Metabolism
The renal kallikrein-kinin system, the activity of which appears to be interrelated
with the RAS and prostaglandins, may participate in the control of RBF and
function by altering the tone of renal and extrarenal blood vessels, and by directly
...
6
The Role of Mast Cells and Plasma
Kallikrein in Mammary ...
Chapter 6 Future Directions The work presented in this thesis establishes the
importance of plasma kallikrein (PKal) in plasminogen activation in the mammary
gland during involution (Chapter 3) as well as identifies a role for mast cells in ...
Jennifer Noel Lilla, 2008
7
Asthma and COPD: Basic Mechanisms and Clinical Management
The historical name, “kallikrein”, is still used to refer to the most physiologically
important kininogenases from blood (plasma kallikrein) and from the major
exocrine organs (tissue, or glandular, kallikrein).This shared nomenclature is ...
Peter J. Barnes, Jeffrey M. Drazen, Stephen I. Rennard, 2002
8
Renin Angiotensin System and Cardiovascular Disease
Together with HMWK and Hageman factor, plasma kallikrein is involved in
coagulation, fibrinolysis, and possibly activation of the complement system. The
plasma kallikrein-HMWK system, acting through the release of bradykinin, could
be ...
Walmor C. DeMello, Edward D. Frohlich, 2009
9
Pharmaceutical Chemistry of Antihypertensive Agents
The amino acid sequence of glandular kallikrein from the guinea pig prostate
was investigated by Dunbar et al.235 The extent of sequence identity with the
kallikrein family of Ser proteases was found to be greater than 60%. This
substance is ...
Gyorgy Szasz, Zsuzsanna Budvari-Barany, 1990
10
Encyclopedia of Cancer
When the first kallikrein (kallikrein 1) was discovered in 1930, the enzyme was
reported to have a hypotensive effect and be present at high concentrations in
the pancreas, the organ known as kallikreas in Greek. It is now known that
kallikrein ...
10 NOTIZIE DOVE SI INCLUDE IL TERMINE «KALLIKREIN»
Vedi di che si parla nei media nazionali e internazionali e come viene utilizzato il termine ino
kallikrein nel contesto delle seguenti notizie.
BioCryst Pharmaceuticals Short Interest Down 19.9% in June …
BCX4161 is an inhibitor of plasma kallikrein in development as an orally administered treatment for the prevention of attacks with Hereditary ... «Mideast Time, lug 15»
Dyax Corp. Short Interest Down 25.0% in June (DYAX)
Plasma kallikrein, an enzyme found in blood, produces bradykinin, a protein that causes blood vessels to enlarge or dilate, which can cause ... «sleekmoney, lug 15»
Dyax Corp. (NASDAQ:DYAX), Cerner Corporation (NASDAQ:CERN)
... identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. «wsnewspublishers, lug 15»
Biotech Stocks with Pessimistic Trend - Actinium Pharmaceuticals …
... identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. «Wall Street Observer, lug 15»
Anti-Thrombin III Testing Market – Global Industry Analysis, Size …
... inhibitor that inhibits the production of thrombin and other activated serine protease coagulation systems such as factor Xa, IXa and kallikrein. «Medgadget.com, lug 15»
BioCryst Pharmaceuticals Short Interest Down 19.9% in June (BCRX)
BCX4161 is an inhibitor of plasma kallikrein in development as an orally administered treatment for the prevention of attacks with Hereditary Angioedema (HAE). «Dakota Financial News, lug 15»
Premarket Biotech Digest: JNJ Earnings, Celgene Making Deals …
(NASDAQ:DYAX) received a BTD for its candidate DX-2930, an mAb inhibitor of plasma kallikrein (pKal) given as a subcutaneous injection, ... «Seeking Alpha, lug 15»
Zacks Downgrades BioCryst Pharmaceuticals to Sell (BCRX)
BCX4161 is an inhibitor of plasma kallikrein in development as an orally administered treatment for the prevention of attacks with Hereditary ... «WKRB News, lug 15»
Top News: Dyax (NASDAQ:DYAX), MGIC Investment (NYSE:MTG …
Dyax is developing DX-2930, an investigational fully human monoclonal antibody inhibitor of plasma kallikrein (pKal), as a subcutaneous ... «Stock Transcript, lug 15»
BioCryst Pharmaceuticals Lowered to Sell at Zacks (BCRX)
BCX4161 is an inhibitor of plasma kallikrein in development as an orally administered treatment for the prevention of attacks with Hereditary Angioedema (HAE). «Dakota Financial News, lug 15»
